Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>Cannara Biotech, Inc. (TSX: LOVE, OTCQX: LOVFF, Frankfurt: 8CB0) is a vertically integrated producer of affordable, premium-grade cannabis and cannabis-derivative products, operating two mega-facilities in Quebec with 100,000 kg of potential annualized cultivation output.</li><li>Products reach ~50,000 points of distribution across Canada and the company now ranks #8 nationally with ~4% retail market share and is gaining quickly.</li><li>On the latest WTR Small-Cap Spotlight, we were joined by Nick Sosiak, COO and Interim CFO of Cannara, and our host Tim Gerdeman, WTR’s Vice Chair &amp; Co-Founder and Chief Marketing Officer, to discuss market dynamics, the new Curaleaf (CURLF) supply deal, capital allocation, the Geely-aligned board, and the North American strategy.</li></ul>

Cannara Biotech, Inc. (TSX: LOVE, OTCQX: LOVFF, Frankfurt: 8CB0) is a vertically integrated producer of affordable, premium-grade cannabis and cannabis-derivative products, operating two mega-facilities in Quebec with 100,000 kg of potential annualized cultivation output.Products reach ~50,000 points of distribution across Canada and the company now ranks #8 nationally with ~4% retail market share and is gaining quickly.On the latest WTR Small-Cap Spotlight, we were joined by Nick Sosiak, COO and Interim CFO of Cannara, and our host Tim Gerdeman, WTR’s Vice Chair &amp; Co-Founder and Chief Marketing Officer, to discuss market dynamics, the new Curaleaf (CURLF) supply deal, capital allocation, the Geely-aligned board, and the North American strategy.

WTR Small-Cap Spotlight Recap (LOVFF) : Gaining Share in the Canadian Cannabis Market